Comparable stake leader
Warren Hosseinion
SEC ownership of Veraxa Biotech AG
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0002079364.
Disclosed value leader
—
Comparable rows
0/1
Latest evidence
10 Sep 2026
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Warren Hosseinion
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
10 Sep 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0002079364
- Issuer location
- Zurich
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Veraxa Biotech AG (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Warren Hosseinion
Disclosed value leader
—
Comparable rows
0/1
Latest evidence
10 Sep 2026
3/4/5
Some rows are evidence-backed but not safely comparable across classes.
1 rows are not safely comparable across share classes.
Quick read
SEC ownership evidence is available, but the rows are not safely comparable across share classes.
0 of 1 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Warren Hosseinion's linked filing trail.
Detailed SEC evidence table Showing 1-1 of 1 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Warren Hosseinion |
3/4/5
Director
|
—
denominator unverified
|
—
634,692 shares
|
— | 10 Sep 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 20 Oct 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-1 of 1 reporting-owner rows connected to Veraxa Biotech AG. Open a relationship link for the CIK-to-CIK filing trail.
Rows
1
Largest Forms 3/4/5 holder
Warren Hosseinion
Net 12M change
$0
Latest report
10 Sep 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Warren Hosseinion | Director | Mixed | 10 Sep 2026 |
Recent insider transactions for Veraxa Biotech AG
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Warren Hosseinion | Ordinary Shares | Purchase | 0.96% | 6,024 | 634,692 | 10 Sep 2026 | Direct |
* marks a reported price that did not pass the local price check.